ArticleOncogene2000
Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation.
M Llovera et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this papercites it